JOHN C. MORAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Anika Therapeutics, Inc.

Filing Date Source Excerpt
2007-04-27 Mr. Moran joined the Board of Directors of Anika Therapeutics in December 2006. In connection with his appointment to the Board of Directors, Mr. Moran was awarded a stock appreciation right under the 2003 Plan on December 14, 2006. The following table summarizes the compensation paid by the Company to non-employee Directors for the fiscal year ended December 31, 2006. John C. Moran Fees Earned or Paid in Cash ($): $1,000, Stock Awards ($): 0, Option Awards ($): 10,322, Total ($): 11,322.
2008-04-25 Mr. Moran joined the Board of Directors of Anika Therapeutics in December 2006. The Governance and Nominating Committee members include Mr. Moran. The Audit Committee members include Mr. Moran. For fiscal year 2007, each director who was not an employee of Anika Therapeutics received a director's fee of $20,000. John C. Moran received $26,000.
2009-04-28 Mr. Moran joined the Board of Directors of Anika Therapeutics in December 2006. The current members of the Audit Committee are Mr. Land, as Chairperson, Dr. Bower, and Mr. Moran. The current members of the Governance and Nominating Committee are Mr. Wheeler, as Chairperson, and Messrs. Moran and Land. The following table summarizes the compensation paid by the Company to non-employee Directors for the year ended December 31, 2008. John C. Moran received $35,250 in fees and $29,954 in stock awards, totaling $65,204.
2010-04-22 Mr. Moran joined the Board of Directors of Anika Therapeutics in December 2006. The following table summarizes the compensation paid by the Company to non-employee Directors for the year ended December 31, 2009. John C. Moran: Fees Earned or Paid in Cash $41,000, Stock Awards $22,875, Total $63,875.
2011-04-28 Mr. Moran serves on the Audit Committee and Governance and Nominating Committee. For 2010, he received $38,500 in fees and $29,994 in stock awards, totaling $68,494.
2012-04-25 Mr. Moran joined the Board of Directors of Anika Therapeutics in December 2006. He serves on the Audit Committee and the Governance and Nominating Committee. The following table summarizes the compensation paid by the Company to non-employee Directors for the year ended December 31, 2011. John C. Moran received $39,000 in fees earned or paid in cash and $29,994 in stock awards, totaling $68,994.
2013-04-23 Mr. Moran joined the Board of Directors of Anika Therapeutics in December 2006. ... Mr. Moran’s qualifications for membership on the Company’s Board include his prior experience in running an orthopedic division and his knowledge of the medical device industry. ... The current members of the Audit Committee are Mr. Land, as Chairperson, Dr. Bower, and Mr. Moran. ... The current members of the Governance and Nominating Committee are Mr. Wheeler, as Chairperson, and Messrs. Moran and Land. ... The following table summarizes the compensation paid by the Company to non-employee Directors for the year ended December 31, 2012. ... John C. Moran Fees Earned or Paid in Cash $36,500, Stock Awards $29,994, Total $66,494.
2014-04-23 Mr. Moran joined the Board of Directors of Anika Therapeutics in December 2006. Mr. Moran’s qualifications for membership on the Company’s Board include his prior experience in running an orthopedic division and his knowledge of the medical device industry. The current members of the Audit Committee are Mr. Land, as Chairperson, Dr. Bower, and Mr. Moran. The Governance and Nominating Committee current members are Mr. Wheeler, as Chairperson, and Messrs. Moran and Land. The following table summarizes the compensation paid by the Company to non-employee Directors for the year ended December 31, 2013. John C. Moran Fees Earned or Paid in Cash $37,000, Stock Awards $30,001, Total $67,001.
2015-04-23 John C. Moran joined the Board of Directors in December 2006. He serves on the Audit Committee and the Governance and Nominating Committee. The following table summarizes the compensation we paid to non-employee directors for the year ended December 31, 2014. John C. Moran: Fees Paid in Cash $51,750, Stock Awards $59,973, Total $111,723.

Data sourced from SEC filings. Last updated: 2026-02-03